KTTA Pasithea Therapeutics Corp

NASDAQ
$0.53

Pasithea Therapeutics Corp (KTTA) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal Bullish Insiders bought more than they sold over this window — uncommon at any size.
Cluster activity 0 buyers in the last 30 days 1 buyer in the last 90 days 0 sellers in the last 90 days
Insiders buying
4
4 transactions
Insiders selling
0
0 transactions
Purchases
$203.0K
299,999 shares
Sales
$0
0 shares
Net activity
$203.0K
purchases less sales

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: June 17, 2026 , by Coastlands Capital LP .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Coastlands Capital LP 10% Owner Buy 100,000 $0.53 $53.0K 3,835,035
STEINMAN LAWRENCE Director Buy 133,333 $0.75 $100.0K 199,691
Marques Tiago Chief Executive Officer Buy 33,333 $0.75 $25.0K 73,334
Dumesnil Simon Director Buy 33,333 $0.75 $25.0K 35,833

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.